Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.11.2013 | General Gynecology | Ausgabe 5/2013

Archives of Gynecology and Obstetrics 5/2013

Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid

Zeitschrift:
Archives of Gynecology and Obstetrics > Ausgabe 5/2013
Autoren:
Azita Goshtasebi, Somayeh Moukhah, Samira Behboudi Gandevani
Wichtige Hinweise
This trial was registered in the Iranian Registry of Clinical Trials at www.​irct.​ir (IRCT 138802131641N3).

Abstract

Purpose

This study aimed at comparing the efficacy of medroxyprogesterone acetate (MPA) and tranexamic acid (TA) for treating heavy menstrual bleeding of endometrial origin (HMB).

Methods

A randomized controlled trial was carried out in three gynecology clinics in Tehran, Iran. Ninety women with the HMB of endometrial origin were randomized into the study: 44 patients took MPA for 21 days from day 5 and 46 patients took tranexamic acid for 5 days from day 1 of menses for three consecutive menstrual cycles. Blood loss was measured using the pictorial blood loss assessment chart (PBAC); hematological assessments were made before intervention and after treatment. SF-36 and HMB Questionnaire (MQ) were given to assess quality of life. Statistical analysis was performed using t test, Paired t test, χ 2, Mann–Whitney, Wilcoxon signed-rank test, and repeated measure analysis.

Results

PBLC mean score, duration of bleeding and Hb values as well as quality of life were significantly improved in both groups ( P < 0.05). But there was no significant deference between groups. More drug complication and less satisfaction were reported by MPA group ( P = 0.003 and P = 0.002, respectively).

Conclusions

Long-term use of MPA is as effective as Tranexamic acid in treating HMB and increasing quality of life. However, bleeding irregularity side effects of MPA might limit its use.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der Fachzeitschriften, inklusive eines Print-Abos.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 5/2013

Archives of Gynecology and Obstetrics 5/2013Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 30 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Gynäkologie und bleiben Sie gut informiert – ganz bequem per eMail.